Cut It Out: The Role of Gene Editing Technologies in Combating HIV
HIV has been one of the largest public health challenges facing the world in the past few decades. Approximately 36.7 million people were infected with HIV, as reported by the World Health Organization, at the end of 2015. Despite the public attention and large population impacted by this virus, developing a cure for HIV has been particularly difficult. To successfully cure an infected individual the virus would need to be fully eradicated from their body, which is difficult because HIV is extraordinarily good at hiding in a person’s cells. In fact, part of the virus’ replication cycle is to insert itself into the host’s DNA. Once there, HIV appears to be undetectable and it can stay in the cells for the lifetime of the cell. In this state, the virus is termed “latent.”
Topic: Cell Therapy Solutions, Topic: Public Healt..........
The Evolution of Public Health Research—A Summary of the Blog Series
Over the past year, we presented a series of blog posts on The Evolution of Public Health Research, our salute to a profession and area of study that has not only saved many, many millions of lives, but also dramatically improved the length and quality of life as well.
Content: eBook, Topic: Public Health Research, The..........
"Validation" or "Qualification" – What’s the difference?
What is the difference between qualification and validation? This question comes up frequently with both internal and external clients.
Topic: Qualification / Validation, Topic: GMP Biol..........
The Evolution of Public Health Research: The Next Frontier
Topic: Public Health Research, Content: Blog
Proposed Changes to Biospecimen Consent Requirements Dropped from the Revised Common Rule
If you are conducting biospecimen-based research, you are probably aware that on January 18, the long-anticipated revised Common Rule (Title 45 of the CFR, part 46, Federal Policy for the Protection of Human Subjects) was posted to the Federal Register (for some background on the nature of these revisions, see my blog post).
Topic: Biobanking and Biorepository, Topic: Public..........
Collaboration in Biopharma: Harnessing the Power of Cloud-based Technologies
From banking to e-commerce, cloud computing has transformed the landscape of the world economy. It is also gradually changing the face of the biopharma industry. In the scientific world, effective communication and collaboration are essential to successful outcomes. Although biopharma has been slower than some other industries to adopt cloud-based technologies, the field is increasingly relying on the cloud to advance scientific knowledge.
Topic: Biobanking and Biorepository, Content: Post..........
Biospecimen-Based Research and the 21st Century Cures Act
“God Willing, This Bill Will Save Lives.” So said Vice President Joe Biden, in sharing his thoughts on the potential ramifications of the passing of the 21st Century Cures Act (H.R.6), made possible by the bipartisan leadership of Republicans and Democrats in the Senate and the House on December 13th 2016.
Topic: Cell Therapy Solutions, Topic: GMP Biologic..........
A Perspective on "Expanded Access" to Experimental (Cell) Therapies
“Expanded Access,” is a regulatory pathway for physicians to gain access to experimental therapies for patients who usually do not qualify for the clinical trial. This pathway often represents one final chance against a condition that is severely debilitating and/or fatal. Often called “Compassionate Use,” the number of patients and physicians requesting access to experimental therapies has been growing steadily over the past three decades.
Topic: Cold-Chain Logistics, Topic: Cell Therapy S..........
Entrusting Your Biologics with a Service Provider? Important Factors to Consider
Over the past decade, a wave of scientific advances and new technologies have made significant impacts on how medicines are discovered. The drive towards personalized medicine has led to an increased understanding of the molecular and genetic bases of disease. As a result of this increased knowledge, the life sciences industry is shifting its focus from small molecule medicine to biologic medicine, resulting in increased use of biologics in clinical trials and R&D efforts.
Topic: GMP Biologics Management, Content: Blog
Phacilitate Cell and Gene Therapy World 2017: Streamline the path from discovery to cure
The advancements in cell and gene therapy are increasing at a rapid pace and are transforming the way we think about medicine. Whether in research or in the clinic, scientific innovators are acutely aware that every moment counts when working with these valuable therapies. To facilitate knowledge sharing and collaboration, Thermo Fisher Scientific is proud to support Phacilitate Cell & Gene Therapy World 2017 as the Platinum Sponsor.
Topic: Cell Therapy Solutions, Content: Blog
The Evolution of Public Health Research: Malaria, Part 2
Malaria Elimination vs. Eradication, and Genetic Diversity vs. “Freezer Epidemiology”
It is because of its historic mission to eliminate malaria that the CDC is in Atlanta, Georgia. The agency is still deeply involved with the control of malaria, by providing technical assistance around the world, and continuing to protect the US population from the parasite. The CDC estimates that 1,500 people in the USA annually are infected with malaria while traveling, and the CDC tracks these cases and advises the medical community on accurate diagnosis and treatment.
Topic: Public Health Research, The Evolution of Pu..........
Fisher BioServices Top Five Most Popular Blogs of 2016